After 3 months of treatment, 18.4% of patients had right ventricular dilatation, 10% of patients with right / left ventricular > 1, 5.8% had TAPSE <17, and 1.9% had abnormal movement of right ventricle; two cases of thrombosis were detected on echocardiography (1.9%).